Neilson EG: Symposium on the cell biology of tubulointerstitium. Kidney Int 1991, 39:369-556.
Strutz F, Mueller GA: Symposium on Renal Fibrosis: prevention and progression. Kidney Int 1996, 49(suppl 54):1-90.
Eknoyan G, McDonald MA, Appel D, Truong LD: Chronic tubulointerstitial nephritis: correlation between structural and functional findings. Kidney Int 1990, 38:736-743.
Jones CL, Eddy AA: Tubulointerstitial nephritis. Ped Nephrol 1992, 6:572-586.
Nath KA: Tubulointerstitial changes as a major determinant in progression of renal damage. Am J Kidney Dis 1992, 20:1-17.
Bohle A, Muller GA, Wehrmann M et al.: Pathogenesis of chronic renal failure in the primary glomerulopathies, renal vasculopathies and chronic interstitial nephritides. Kidney Int 1996, 49(suppl 54):2-9.
Dodd S: The pathogenesis of tubulointerstitial disease and mechanisms of fibrosis. Curr Top Pathol 1995, 88:117-143.
Haggerty DT, Allen DM: Processing and presentation of self and foreign antigens by the renal proximal tubule. J Immunol 1992, 148:2324-2331.
Nath KA: Reshaping the interstitium by platelet-derived growth factor. Implications for progressive renal disease. Am J Path 1996, 148:1031-1036.
Sedor JR: Cytokines and growth factors in renal injury. Semin Nephrol 1992, 12:428-440.
Wilson CB: Nephritogenic tubulointers-titial antigens. Kidney Int 1991, 39:501-517.
Yamato T, Noble NA, Miller DE, Border WA: Sustained expression of TGF-B1 underlies development of progressive kidney fibrosis. Kidney Int 1994, 45:916-927.
D'Amico G, Ferrario F, Rastaldi MP: Tubulointerstitial damage in glomerular diseases: its role in the progression of renal damage. Am J Kidney Dis 1995,26:124-132.
Eddy AA: Experimental insights into tubulointerstitial disease accompanying primary glomerular lesions. J Am Soc Nephrol 1994, 5:1273-1287.
Magil AB: Tubulointerstitial lesions in human membranous glomeru-lonephritis: relationship to proteinuria. Amer J Kidney Dis 1995, 25:375-379.
Henrich WL, Agodoa LE, Barrett B, Bennett WM et al.: Analgesics and the Kidney. Summary and Recommendations to the Scientific Advisory Board of the National Kidney Foundation. Am J Kidney Dis 1996, 27:162-165
Noels LM, Elseviers NM, DeBroe ME: Impact of legislative measures of the sales of analgesics and the subsequent prevalence of analgesic nephropathy: a comparative study in France, Sweden and Belgium. Nephrol Dial Transplant 1995, 10:167-174.
Perneger TV, Whelton PK, Klag MJ: Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal anti-inflammatory drugs. N Engl J Med 1994, 331:1675-1679.
Sandler DP, Burr FR, Weinberg CR: Nonsteroidal anti-inflammatory drugs and risk of chronic renal failure. Ann Intern Med 1991, 115:165-172.
Sandler DP, Smith JC, Weinberg CR et al.: Analgesic use and chronic renal disease. N Engl J Med 1989, 320:1238-1243.
Boton R, Gaviria M, Battle DC: Prevalence, pathogenesis, and treatment of renal dysfunction associated with chronic lithium therapy. Am J Kidney Dis 1990, 10:329-345.
Myer BD, Newton L: Cyclosporine induced chronic nephropathy: an obliter-ative microvascular renal injury. J Am Soc Nephrol 1991, 2(suppl 1):4551.
Batuman V, Maesaka JK, Haddad B et al.: Role of lead in gouty nephropathy. N Engl J Med 1981, 304:520-523.
Fowler BA: Mechanisms of kidney cell injury from metals. Environ Health Perspec 1993, 100:57-63.
Hu H: A 50-year follow-up of childhood plumbism. Hypertension, renal function and hemoglobin levels among survivors. Am J Dis Child 1991, 145:681-687.
Staessen JA, Lauwerys RR, Buchet JP et al.: Impairment of renal function with increasing lead concentrations in the general population. N Engl J Med 1992, 327:151-156.
Vedeen RP: Environmental renal disease: lead. cadmium, and Balkan endemic nephropathy. Kidney Int 34(suppl):4-8.
Ischemic Vascular Disease
Freedman BI, Ishander SS, Buckalew VM et al.: Renal biopsy findings in presumed hypertensive nephrosclerosis. Am J Nephrol 1994, 14:90-94.
Meyrier A, Simon P: Nephroangiosclerosis and hypertension: things are not as simple as you might think. Nephrol Dial Transplant 1996, 11:2116-1220.
Schlesinger SD, Tankersley MR, Curtis JJ: Clinical documentation of end stage renal disease due to hypertension. Am J Kidney Dis 1994, 23:655-660.
Arant BS Jr: Vesicoureteric reflux and renal injury. Am J Kidney Dis 1991, 17:491-511.
Diamond JR: Macrophages and progressive renal disease in experimental hydronephrosis. Am J Kidney Dis 1995, 26:133-140.
Klahr S: New insight into consequences and mechanisms of renal impairment in obstructive nephropathy. Am J Kidney Dis 1991, 18:689-699.
Allon M: Renal abnormalities in sickle cell disease. Arch Intern Med 1990, 150:501-504.
Falk RJ, Scheinmann JI, Phillips G et al.: Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin converting enzyme. N Engl J Med 1992, 326:910-915.
Ivanyi B: Frequency of light chain deposition nephropathy relative to renal amyloidosis and Bence Jones cast nephropathy in a necropsy study of patients with myeloma. Arch Pathol Lab Med 1990, 114:986-987.
Rota S, Mougenot B, Baudouin M: Multiple myeloma and severe renal failure: a clinicopathologic study of outcome and prognosis in 34 patients. Medicine 1987, 66:126-137.
Sanders PW, Herrera GA, Kirk KA: Spectrum of glomerular and tubuloint-erstitial renal lesions associated with monotypical immunoglobulin light chain deposition. Lab Invest 1991, 64:527-537.
Was this article helpful?
Do You Suffer From High Blood Pressure? Do You Feel Like This Silent Killer Might Be Stalking You? Have you been diagnosed or pre-hypertension and hypertension? Then JOIN THE CROWD Nearly 1 in 3 adults in the United States suffer from High Blood Pressure and only 1 in 3 adults are actually aware that they have it.